Singular Genomics Systems, Inc.
OMICDelisted Feb 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001850906
Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Singular Genomics Systems, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 24 | 1 | 22 | −1 |
| Shares | 709.8K | 20.4K | 1.17M | +485.6K (+70.4%) |
| Value | $6.00M | $172.7K | $18.4M | +$12.6M (+216.0%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Singular Genomics Systems, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 372,000 | $5.83M | 0.42% |
| CRCM LP | 101,100 | $1.58M | 1.03% |
| UBS Group AG | 77,984 | $1.22M | 0.00% |
| BlackRock, Inc. | 15,734 | $246.6K | 0.00% |
Sold out (5)
Institutions that held Singular Genomics Systems, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Casdin Capital, LLC | 44,129 | $372.9K |
| OrbiMed Advisors LLC | 18,023 | $152.3K |
| Rhumbline Advisers | 55 | $464 |
| Qube Research & Technologies Ltd | 22 | $186 |
| Capital Advisors, Ltd. LLC | 33 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held Singular Genomics Systems, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 20,437 | $172.7K |